The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Short-acting Interferon Injection Market Research Report 2025
Synopsis
Interferons are proteins that are part of your natural defenses. They tell your immune system that germs or cancer cells are in your body. Interferon injection is a broad-spectrum antiviral agent that does not directly kill or inhibit viruses, but uses cell surface receptors to cause cells to produce antiviral proteins, thereby inhibiting virus replication. Interferons are currently used clinically to treat viral infections such as hepatitis C, cancers including non-Hodgkin’s lymphoma, and autoimmune diseases such as multiple sclerosis.
Short-acting interferon injection is an interferon drug given once daily by intramuscular injection.
The global Short-acting Interferon Injection market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for Short-acting Interferon Injection is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Short-acting Interferon Injection is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Short-acting Interferon Injection include Bayer, Novartis, Biogen, Merck KGaA, Anhui Anke Biotechnology, Beijing Tri-Prime Gene Pharmaceutical, Beijing Kawin Technology, Shan Dong Kexing Biopharm, Shanghai Huaxin High Biotechnology, Harbin Pharmaceutical Group, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Short-acting Interferon Injection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Short-acting Interferon Injection.
The Short-acting Interferon Injection market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Short-acting Interferon Injection market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Short-acting Interferon Injection manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Bayer
Novartis
Biogen
Merck KGaA
Anhui Anke Biotechnology
Beijing Tri-Prime Gene Pharmaceutical
Beijing Kawin Technology
Shan Dong Kexing Biopharm
Shanghai Huaxin High Biotechnology
Harbin Pharmaceutical Group
Sinobioway Biomedicine
3SBio Group
Changchun Heber Biological Technology
Segment by Type
Interferon α1b Injection
Interferon α2a Injection
Interferon α2b Injection
Interferon β1a Injection
Interferon β1b Injection
Segment by Application
Viral Diseases
Malignant Tumors
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Short-acting Interferon Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Short-acting Interferon Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Interferons are proteins that are part of your natural defenses. They tell your immune system that germs or cancer cells are in your body. Interferon injection is a broad-spectrum antiviral agent that does not directly kill or inhibit viruses, but uses cell surface receptors to cause cells to produce antiviral proteins, thereby inhibiting virus replication. Interferons are currently used clinically to treat viral infections such as hepatitis C, cancers including non-Hodgkin’s lymphoma, and autoimmune diseases such as multiple sclerosis.
Short-acting interferon injection is an interferon drug given once daily by intramuscular injection.
The global Short-acting Interferon Injection market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for Short-acting Interferon Injection is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Short-acting Interferon Injection is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Short-acting Interferon Injection include Bayer, Novartis, Biogen, Merck KGaA, Anhui Anke Biotechnology, Beijing Tri-Prime Gene Pharmaceutical, Beijing Kawin Technology, Shan Dong Kexing Biopharm, Shanghai Huaxin High Biotechnology, Harbin Pharmaceutical Group, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Short-acting Interferon Injection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Short-acting Interferon Injection.
The Short-acting Interferon Injection market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Short-acting Interferon Injection market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Short-acting Interferon Injection manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Bayer
Novartis
Biogen
Merck KGaA
Anhui Anke Biotechnology
Beijing Tri-Prime Gene Pharmaceutical
Beijing Kawin Technology
Shan Dong Kexing Biopharm
Shanghai Huaxin High Biotechnology
Harbin Pharmaceutical Group
Sinobioway Biomedicine
3SBio Group
Changchun Heber Biological Technology
Segment by Type
Interferon α1b Injection
Interferon α2a Injection
Interferon α2b Injection
Interferon β1a Injection
Interferon β1b Injection
Segment by Application
Viral Diseases
Malignant Tumors
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Short-acting Interferon Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Short-acting Interferon Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Short-acting Interferon Injection Market Overview
1.1 Product Definition
1.2 Short-acting Interferon Injection by Type
1.2.1 Global Short-acting Interferon Injection Market Value Comparison by Type (2024-2030)
1.2.2 Interferon α1b Injection
1.2.3 Interferon α2a Injection
1.2.4 Interferon α2b Injection
1.2.5 Interferon β1a Injection
1.2.6 Interferon β1b Injection
1.3 Short-acting Interferon Injection by Application
1.3.1 Global Short-acting Interferon Injection Market Value by Application (2024-2030)
1.3.2 Viral Diseases
1.3.3 Malignant Tumors
1.4 Global Short-acting Interferon Injection Market Size Estimates and Forecasts
1.4.1 Global Short-acting Interferon Injection Revenue 2019-2030
1.4.2 Global Short-acting Interferon Injection Sales 2019-2030
1.4.3 Global Short-acting Interferon Injection Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Short-acting Interferon Injection Market Competition by Manufacturers
2.1 Global Short-acting Interferon Injection Sales Market Share by Manufacturers (2019-2024)
2.2 Global Short-acting Interferon Injection Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Short-acting Interferon Injection Average Price by Manufacturers (2019-2024)
2.4 Global Key Players of Short-acting Interferon Injection, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Short-acting Interferon Injection, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Short-acting Interferon Injection, Product Type & Application
2.7 Global Key Manufacturers of Short-acting Interferon Injection, Date of Enter into This Industry
2.8 Global Short-acting Interferon Injection Market Competitive Situation and Trends
2.8.1 Global Short-acting Interferon Injection Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Short-acting Interferon Injection Players Market Share by Revenue
2.8.3 Global Short-acting Interferon Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Short-acting Interferon Injection Market Scenario by Region
3.1 Global Short-acting Interferon Injection Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Short-acting Interferon Injection Sales by Region: 2019-2030
3.2.1 Global Short-acting Interferon Injection Sales by Region: 2019-2024
3.2.2 Global Short-acting Interferon Injection Sales by Region: 2025-2030
3.3 Global Short-acting Interferon Injection Revenue by Region: 2019-2030
3.3.1 Global Short-acting Interferon Injection Revenue by Region: 2019-2024
3.3.2 Global Short-acting Interferon Injection Revenue by Region: 2025-2030
3.4 North America Short-acting Interferon Injection Market Facts & Figures by Country
3.4.1 North America Short-acting Interferon Injection Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Short-acting Interferon Injection Sales by Country (2019-2030)
3.4.3 North America Short-acting Interferon Injection Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Short-acting Interferon Injection Market Facts & Figures by Country
3.5.1 Europe Short-acting Interferon Injection Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Short-acting Interferon Injection Sales by Country (2019-2030)
3.5.3 Europe Short-acting Interferon Injection Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Short-acting Interferon Injection Market Facts & Figures by Region
3.6.1 Asia Pacific Short-acting Interferon Injection Market Size by Region: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Short-acting Interferon Injection Sales by Region (2019-2030)
3.6.3 Asia Pacific Short-acting Interferon Injection Revenue by Region (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Short-acting Interferon Injection Market Facts & Figures by Country
3.7.1 Latin America Short-acting Interferon Injection Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Short-acting Interferon Injection Sales by Country (2019-2030)
3.7.3 Latin America Short-acting Interferon Injection Revenue by Country
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Short-acting Interferon Injection Market Facts & Figures by Country
3.8.1 Middle East and Africa Short-acting Interferon Injection Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Short-acting Interferon Injection Sales by Country (2019-2030)
3.8.3 Middle East and Africa Short-acting Interferon Injection Revenue by Country
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Short-acting Interferon Injection Sales by Type (2019-2030)
4.1.1 Global Short-acting Interferon Injection Sales by Type (2019-2024)
4.1.2 Global Short-acting Interferon Injection Sales by Type (2025-2030)
4.1.3 Global Short-acting Interferon Injection Sales Market Share by Type (2019-2030)
4.2 Global Short-acting Interferon Injection Revenue by Type (2019-2030)
4.2.1 Global Short-acting Interferon Injection Revenue by Type (2019-2024)
4.2.2 Global Short-acting Interferon Injection Revenue by Type (2025-2030)
4.2.3 Global Short-acting Interferon Injection Revenue Market Share by Type (2019-2030)
4.3 Global Short-acting Interferon Injection Price by Type (2019-2030)
5 Segment by Application
5.1 Global Short-acting Interferon Injection Sales by Application (2019-2030)
5.1.1 Global Short-acting Interferon Injection Sales by Application (2019-2024)
5.1.2 Global Short-acting Interferon Injection Sales by Application (2025-2030)
5.1.3 Global Short-acting Interferon Injection Sales Market Share by Application (2019-2030)
5.2 Global Short-acting Interferon Injection Revenue by Application (2019-2030)
5.2.1 Global Short-acting Interferon Injection Revenue by Application (2019-2024)
5.2.2 Global Short-acting Interferon Injection Revenue by Application (2025-2030)
5.2.3 Global Short-acting Interferon Injection Revenue Market Share by Application (2019-2030)
5.3 Global Short-acting Interferon Injection Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Bayer
6.1.1 Bayer Company Information
6.1.2 Bayer Description and Business Overview
6.1.3 Bayer Short-acting Interferon Injection Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Bayer Short-acting Interferon Injection Product Portfolio
6.1.5 Bayer Recent Developments/Updates
6.2 Novartis
6.2.1 Novartis Company Information
6.2.2 Novartis Description and Business Overview
6.2.3 Novartis Short-acting Interferon Injection Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Novartis Short-acting Interferon Injection Product Portfolio
6.2.5 Novartis Recent Developments/Updates
6.3 Biogen
6.3.1 Biogen Company Information
6.3.2 Biogen Description and Business Overview
6.3.3 Biogen Short-acting Interferon Injection Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Biogen Short-acting Interferon Injection Product Portfolio
6.3.5 Biogen Recent Developments/Updates
6.4 Merck KGaA
6.4.1 Merck KGaA Company Information
6.4.2 Merck KGaA Description and Business Overview
6.4.3 Merck KGaA Short-acting Interferon Injection Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Merck KGaA Short-acting Interferon Injection Product Portfolio
6.4.5 Merck KGaA Recent Developments/Updates
6.5 Anhui Anke Biotechnology
6.5.1 Anhui Anke Biotechnology Company Information
6.5.2 Anhui Anke Biotechnology Description and Business Overview
6.5.3 Anhui Anke Biotechnology Short-acting Interferon Injection Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Anhui Anke Biotechnology Short-acting Interferon Injection Product Portfolio
6.5.5 Anhui Anke Biotechnology Recent Developments/Updates
6.6 Beijing Tri-Prime Gene Pharmaceutical
6.6.1 Beijing Tri-Prime Gene Pharmaceutical Company Information
6.6.2 Beijing Tri-Prime Gene Pharmaceutical Description and Business Overview
6.6.3 Beijing Tri-Prime Gene Pharmaceutical Short-acting Interferon Injection Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Beijing Tri-Prime Gene Pharmaceutical Short-acting Interferon Injection Product Portfolio
6.6.5 Beijing Tri-Prime Gene Pharmaceutical Recent Developments/Updates
6.7 Beijing Kawin Technology
6.7.1 Beijing Kawin Technology Company Information
6.7.2 Beijing Kawin Technology Description and Business Overview
6.7.3 Beijing Kawin Technology Short-acting Interferon Injection Sales, Revenue and Gross Margin (2019-2024)
6.7.4 Beijing Kawin Technology Short-acting Interferon Injection Product Portfolio
6.7.5 Beijing Kawin Technology Recent Developments/Updates
6.8 Shan Dong Kexing Biopharm
6.8.1 Shan Dong Kexing Biopharm Company Information
6.8.2 Shan Dong Kexing Biopharm Description and Business Overview
6.8.3 Shan Dong Kexing Biopharm Short-acting Interferon Injection Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Shan Dong Kexing Biopharm Short-acting Interferon Injection Product Portfolio
6.8.5 Shan Dong Kexing Biopharm Recent Developments/Updates
6.9 Shanghai Huaxin High Biotechnology
6.9.1 Shanghai Huaxin High Biotechnology Company Information
6.9.2 Shanghai Huaxin High Biotechnology Description and Business Overview
6.9.3 Shanghai Huaxin High Biotechnology Short-acting Interferon Injection Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Shanghai Huaxin High Biotechnology Short-acting Interferon Injection Product Portfolio
6.9.5 Shanghai Huaxin High Biotechnology Recent Developments/Updates
6.10 Harbin Pharmaceutical Group
6.10.1 Harbin Pharmaceutical Group Company Information
6.10.2 Harbin Pharmaceutical Group Description and Business Overview
6.10.3 Harbin Pharmaceutical Group Short-acting Interferon Injection Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Harbin Pharmaceutical Group Short-acting Interferon Injection Product Portfolio
6.10.5 Harbin Pharmaceutical Group Recent Developments/Updates
6.11 Sinobioway Biomedicine
6.11.1 Sinobioway Biomedicine Company Information
6.11.2 Sinobioway Biomedicine Description and Business Overview
6.11.3 Sinobioway Biomedicine Short-acting Interferon Injection Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Sinobioway Biomedicine Short-acting Interferon Injection Product Portfolio
6.11.5 Sinobioway Biomedicine Recent Developments/Updates
6.12 3SBio Group
6.12.1 3SBio Group Company Information
6.12.2 3SBio Group Description and Business Overview
6.12.3 3SBio Group Short-acting Interferon Injection Sales, Revenue and Gross Margin (2019-2024)
6.12.4 3SBio Group Short-acting Interferon Injection Product Portfolio
6.12.5 3SBio Group Recent Developments/Updates
6.13 Changchun Heber Biological Technology
6.13.1 Changchun Heber Biological Technology Company Information
6.13.2 Changchun Heber Biological Technology Description and Business Overview
6.13.3 Changchun Heber Biological Technology Short-acting Interferon Injection Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Changchun Heber Biological Technology Short-acting Interferon Injection Product Portfolio
6.13.5 Changchun Heber Biological Technology Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Short-acting Interferon Injection Industry Chain Analysis
7.2 Short-acting Interferon Injection Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Short-acting Interferon Injection Production Mode & Process
7.4 Short-acting Interferon Injection Sales and Marketing
7.4.1 Short-acting Interferon Injection Sales Channels
7.4.2 Short-acting Interferon Injection Distributors
7.5 Short-acting Interferon Injection Customers
8 Short-acting Interferon Injection Market Dynamics
8.1 Short-acting Interferon Injection Industry Trends
8.2 Short-acting Interferon Injection Market Drivers
8.3 Short-acting Interferon Injection Market Challenges
8.4 Short-acting Interferon Injection Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Short-acting Interferon Injection Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Short-acting Interferon Injection Market Value by Application (2024-2030) & (US$ Million)
Table 3. Global Short-acting Interferon Injection Market Competitive Situation by Manufacturers in 2023
Table 4. Global Short-acting Interferon Injection Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Short-acting Interferon Injection Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Short-acting Interferon Injection Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Short-acting Interferon Injection Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Short-acting Interferon Injection Average Price (US$/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Short-acting Interferon Injection, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Short-acting Interferon Injection, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Short-acting Interferon Injection, Product Type & Application
Table 12. Global Key Manufacturers of Short-acting Interferon Injection, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Short-acting Interferon Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Short-acting Interferon Injection as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Short-acting Interferon Injection Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Short-acting Interferon Injection Sales by Region (2019-2024) & (K Units)
Table 18. Global Short-acting Interferon Injection Sales Market Share by Region (2019-2024)
Table 19. Global Short-acting Interferon Injection Sales by Region (2025-2030) & (K Units)
Table 20. Global Short-acting Interferon Injection Sales Market Share by Region (2025-2030)
Table 21. Global Short-acting Interferon Injection Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Short-acting Interferon Injection Revenue Market Share by Region (2019-2024)
Table 23. Global Short-acting Interferon Injection Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Short-acting Interferon Injection Revenue Market Share by Region (2025-2030)
Table 25. North America Short-acting Interferon Injection Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Short-acting Interferon Injection Sales by Country (2019-2024) & (K Units)
Table 27. North America Short-acting Interferon Injection Sales by Country (2025-2030) & (K Units)
Table 28. North America Short-acting Interferon Injection Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Short-acting Interferon Injection Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Short-acting Interferon Injection Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Short-acting Interferon Injection Sales by Country (2019-2024) & (K Units)
Table 32. Europe Short-acting Interferon Injection Sales by Country (2025-2030) & (K Units)
Table 33. Europe Short-acting Interferon Injection Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Short-acting Interferon Injection Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Short-acting Interferon Injection Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Short-acting Interferon Injection Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Short-acting Interferon Injection Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Short-acting Interferon Injection Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Short-acting Interferon Injection Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Short-acting Interferon Injection Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Short-acting Interferon Injection Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Short-acting Interferon Injection Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Short-acting Interferon Injection Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Short-acting Interferon Injection Revenue Market Share by Country (2019-2024)
Table 45. Middle East and Africa Short-acting Interferon Injection Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East and Africa Short-acting Interferon Injection Sales by Country (2019-2024) & (K Units)
Table 47. Middle East and Africa Short-acting Interferon Injection Sales by Country (2025-2030) & (K Units)
Table 48. Middle East and Africa Short-acting Interferon Injection Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East and Africa Short-acting Interferon Injection Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Short-acting Interferon Injection Sales (K Units) by Type (2019-2024)
Table 51. Global Short-acting Interferon Injection Sales (K Units) by Type (2025-2030)
Table 52. Global Short-acting Interferon Injection Sales Market Share by Type (2019-2024)
Table 53. Global Short-acting Interferon Injection Sales Market Share by Type (2025-2030)
Table 54. Global Short-acting Interferon Injection Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Short-acting Interferon Injection Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Short-acting Interferon Injection Revenue Market Share by Type (2019-2024)
Table 57. Global Short-acting Interferon Injection Revenue Market Share by Type (2025-2030)
Table 58. Global Short-acting Interferon Injection Price (US$/Unit) by Type (2019-2024)
Table 59. Global Short-acting Interferon Injection Price (US$/Unit) by Type (2025-2030)
Table 60. Global Short-acting Interferon Injection Sales (K Units) by Application (2019-2024)
Table 61. Global Short-acting Interferon Injection Sales (K Units) by Application (2025-2030)
Table 62. Global Short-acting Interferon Injection Sales Market Share by Application (2019-2024)
Table 63. Global Short-acting Interferon Injection Sales Market Share by Application (2025-2030)
Table 64. Global Short-acting Interferon Injection Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Short-acting Interferon Injection Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Short-acting Interferon Injection Revenue Market Share by Application (2019-2024)
Table 67. Global Short-acting Interferon Injection Revenue Market Share by Application (2025-2030)
Table 68. Global Short-acting Interferon Injection Price (US$/Unit) by Application (2019-2024)
Table 69. Global Short-acting Interferon Injection Price (US$/Unit) by Application (2025-2030)
Table 70. Bayer Company Information
Table 71. Bayer Description and Business Overview
Table 72. Bayer Short-acting Interferon Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 73. Bayer Short-acting Interferon Injection Product
Table 74. Bayer Recent Developments/Updates
Table 75. Novartis Company Information
Table 76. Novartis Description and Business Overview
Table 77. Novartis Short-acting Interferon Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. Novartis Short-acting Interferon Injection Product
Table 79. Novartis Recent Developments/Updates
Table 80. Biogen Company Information
Table 81. Biogen Description and Business Overview
Table 82. Biogen Short-acting Interferon Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. Biogen Short-acting Interferon Injection Product
Table 84. Biogen Recent Developments/Updates
Table 85. Merck KGaA Company Information
Table 86. Merck KGaA Description and Business Overview
Table 87. Merck KGaA Short-acting Interferon Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. Merck KGaA Short-acting Interferon Injection Product
Table 89. Merck KGaA Recent Developments/Updates
Table 90. Anhui Anke Biotechnology Company Information
Table 91. Anhui Anke Biotechnology Description and Business Overview
Table 92. Anhui Anke Biotechnology Short-acting Interferon Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. Anhui Anke Biotechnology Short-acting Interferon Injection Product
Table 94. Anhui Anke Biotechnology Recent Developments/Updates
Table 95. Beijing Tri-Prime Gene Pharmaceutical Company Information
Table 96. Beijing Tri-Prime Gene Pharmaceutical Description and Business Overview
Table 97. Beijing Tri-Prime Gene Pharmaceutical Short-acting Interferon Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 98. Beijing Tri-Prime Gene Pharmaceutical Short-acting Interferon Injection Product
Table 99. Beijing Tri-Prime Gene Pharmaceutical Recent Developments/Updates
Table 100. Beijing Kawin Technology Company Information
Table 101. Beijing Kawin Technology Description and Business Overview
Table 102. Beijing Kawin Technology Short-acting Interferon Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 103. Beijing Kawin Technology Short-acting Interferon Injection Product
Table 104. Beijing Kawin Technology Recent Developments/Updates
Table 105. Shan Dong Kexing Biopharm Company Information
Table 106. Shan Dong Kexing Biopharm Description and Business Overview
Table 107. Shan Dong Kexing Biopharm Short-acting Interferon Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 108. Shan Dong Kexing Biopharm Short-acting Interferon Injection Product
Table 109. Shan Dong Kexing Biopharm Recent Developments/Updates
Table 110. Shanghai Huaxin High Biotechnology Company Information
Table 111. Shanghai Huaxin High Biotechnology Description and Business Overview
Table 112. Shanghai Huaxin High Biotechnology Short-acting Interferon Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 113. Shanghai Huaxin High Biotechnology Short-acting Interferon Injection Product
Table 114. Shanghai Huaxin High Biotechnology Recent Developments/Updates
Table 115. Harbin Pharmaceutical Group Company Information
Table 116. Harbin Pharmaceutical Group Description and Business Overview
Table 117. Harbin Pharmaceutical Group Short-acting Interferon Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 118. Harbin Pharmaceutical Group Short-acting Interferon Injection Product
Table 119. Harbin Pharmaceutical Group Recent Developments/Updates
Table 120. Sinobioway Biomedicine Company Information
Table 121. Sinobioway Biomedicine Description and Business Overview
Table 122. Sinobioway Biomedicine Short-acting Interferon Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 123. Sinobioway Biomedicine Short-acting Interferon Injection Product
Table 124. Sinobioway Biomedicine Recent Developments/Updates
Table 125. 3SBio Group Company Information
Table 126. 3SBio Group Description and Business Overview
Table 127. 3SBio Group Short-acting Interferon Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 128. 3SBio Group Short-acting Interferon Injection Product
Table 129. 3SBio Group Recent Developments/Updates
Table 130. Changchun Heber Biological Technology Company Information
Table 131. Changchun Heber Biological Technology Description and Business Overview
Table 132. Changchun Heber Biological Technology Short-acting Interferon Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 133. Changchun Heber Biological Technology Short-acting Interferon Injection Product
Table 134. Changchun Heber Biological Technology Recent Developments/Updates
Table 135. Key Raw Materials Lists
Table 136. Raw Materials Key Suppliers Lists
Table 137. Short-acting Interferon Injection Distributors List
Table 138. Short-acting Interferon Injection Customers List
Table 139. Short-acting Interferon Injection Market Trends
Table 140. Short-acting Interferon Injection Market Drivers
Table 141. Short-acting Interferon Injection Market Challenges
Table 142. Short-acting Interferon Injection Market Restraints
Table 143. Research Programs/Design for This Report
Table 144. Key Data Information from Secondary Sources
Table 145. Key Data Information from Primary Sources
Table 146. Authors List of This Report
List of Figures
Figure 1. Product Picture of Short-acting Interferon Injection
Figure 2. Global Short-acting Interferon Injection Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Short-acting Interferon Injection Market Share by Type: 2023 & 2030
Figure 4. Interferon α1b Injection Product Picture
Figure 5. Interferon α2a Injection Product Picture
Figure 6. Interferon α2b Injection Product Picture
Figure 7. Interferon β1a Injection Product Picture
Figure 8. Interferon β1b Injection Product Picture
Figure 9. Global Short-acting Interferon Injection Market Value by Application (2024-2030) & (US$ Million)
Figure 10. Global Short-acting Interferon Injection Market Share by Application: 2023 & 2030
Figure 11. Viral Diseases
Figure 12. Malignant Tumors
Figure 13. Global Short-acting Interferon Injection Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 14. Global Short-acting Interferon Injection Market Size (2019-2030) & (US$ Million)
Figure 15. Global Short-acting Interferon Injection Sales (2019-2030) & (K Units)
Figure 16. Global Short-acting Interferon Injection Average Price (US$/Unit) & (2019-2030)
Figure 17. Short-acting Interferon Injection Report Years Considered
Figure 18. Short-acting Interferon Injection Sales Share by Manufacturers in 2023
Figure 19. Global Short-acting Interferon Injection Revenue Share by Manufacturers in 2023
Figure 20. Global 5 and 10 Largest Short-acting Interferon Injection Players: Market Share by Revenue in Short-acting Interferon Injection in 2023
Figure 21. Short-acting Interferon Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 22. Global Short-acting Interferon Injection Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 23. North America Short-acting Interferon Injection Sales Market Share by Country (2019-2030)
Figure 24. North America Short-acting Interferon Injection Revenue Market Share by Country (2019-2030)
Figure 25. United States Short-acting Interferon Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 26. Canada Short-acting Interferon Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 27. Europe Short-acting Interferon Injection Sales Market Share by Country (2019-2030)
Figure 28. Europe Short-acting Interferon Injection Revenue Market Share by Country (2019-2030)
Figure 29. Germany Short-acting Interferon Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. France Short-acting Interferon Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. U.K. Short-acting Interferon Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Italy Short-acting Interferon Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. Russia Short-acting Interferon Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 34. Asia Pacific Short-acting Interferon Injection Sales Market Share by Region (2019-2030)
Figure 35. Asia Pacific Short-acting Interferon Injection Revenue Market Share by Region (2019-2030)
Figure 36. China Short-acting Interferon Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. Japan Short-acting Interferon Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. South Korea Short-acting Interferon Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. India Short-acting Interferon Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Australia Short-acting Interferon Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. China Taiwan Short-acting Interferon Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Southeast Asia Short-acting Interferon Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Latin America Short-acting Interferon Injection Sales Market Share by Country (2019-2030)
Figure 44. Mexico Short-acting Interferon Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Brazil Short-acting Interferon Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Argentina Short-acting Interferon Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Colombia Short-acting Interferon Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Middle East and Africa Short-acting Interferon Injection Sales Market Share by Country (2019-2030)
Figure 49. Middle East and Africa Short-acting Interferon Injection Revenue Market Share by Country (2019-2030)
Figure 50. Turkey Short-acting Interferon Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. Saudi Arabia Short-acting Interferon Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. UAE Short-acting Interferon Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. Global Sales Market Share of Short-acting Interferon Injection by Type (2019-2030)
Figure 54. Global Revenue Market Share of Short-acting Interferon Injection by Type (2019-2030)
Figure 55. Global Short-acting Interferon Injection Price (US$/Unit) by Type (2019-2030)
Figure 56. Global Sales Market Share of Short-acting Interferon Injection by Application (2019-2030)
Figure 57. Global Revenue Market Share of Short-acting Interferon Injection by Application (2019-2030)
Figure 58. Global Short-acting Interferon Injection Price (US$/Unit) by Application (2019-2030)
Figure 59. Short-acting Interferon Injection Value Chain
Figure 60. Short-acting Interferon Injection Production Process
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
